Ind-Swift Labs approved to issue up to Rs. 5 billion in convertibles

By Devika Patel

Knoxville, Tenn., Sept. 22 - Ind-Swift Laboratories Ltd. informed the Bombay Stock Exchange that it received approval to issue up to Rs. 5 billion in foreign-currency convertible bonds at an annual general meeting on Wednesday.

The company also is considering Global Depositary Receipts.

Ind-Swift is a Chandigarh, India, pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.